Rob Fried

Currently holds a position at Niagen Bioscience Inc

3.9

3.9

Position	Company	Period
President, Chief Executive Officer, Chief Operating Officer, Chief Strategy Officer, Director	Niagen Bioscience Inc	June 22, 2018 -
President, Chief Strategy Officer, Chief Operating Officer, Director	Niagen Bioscience Inc	Jan. 8, 2018 - June 22, 2018
Director	Fluent Inc	June 16, 2015 - March 26, 2018
President, Chief Strategy Officer, Director	Niagen Bioscience Inc	March 12, 2017 - Jan. 8, 2018
Independent Director	Niagen Bioscience Inc	July 13, 2015 - March 12, 2017
Independent Chairman of the Board	Fluent Inc	Aug. 1, 2011 - June 16, 2015

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-06-01	2023-05-31	Niagen Bioscience Inc (NAGE)	B Purchase	23,862 +26.7% 130.12 US$977,947	23,862 +26.7%	130.12	US$977,947
2022-10-03	2022-09-30	Niagen Bioscience Inc (NAGE)	B Purchase	72,698 +4.6% 456.43 US$1,476,740	72,698 +4.6%	456.43	US$1,476,740
2022-03-16	2022-03-16	Niagen Bioscience Inc (NAGE)	B Purchase	14,793 -12.9% 131.37 US$1,572,492	14,793 -12.9%	131.37	US$1,572,492
2020-05-19	2020-05-19	Niagen Bioscience Inc (NAGE)	B Purchase	1,000 +0.1% 4.69 US$4,690	1,000 +0.1%	4.69	US$4,690
2019-11-15	2019-11-14	Niagen Bioscience Inc (NAGE)	B Purchase	10,000 +0.7% 3.09 US$30,900	10,000 +0.7%	3.09	US$30,900
2019-05-22	2019-05-21	Niagen Bioscience Inc (NAGE)	B Purchase	2,253 +0.2% 4.43 US$9,981	2,253 +0.2%	4.43	US$9,981
2019-03-15	2019-03-15	Niagen Bioscience Inc (NAGE)	B Purchase	5,000 +0.4% 3.80 US$19,000	5,000 +0.4%	3.80	US$19,000